Hannover Re/€HNR1
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Hannover Re
Hannover Re, known formally as Hannover Rück SE, is a global reinsurance company headquartered in Hannover, Germany. Founded in 1966, the company operates in the insurance sector, providing reinsurance products and services across both life/health and property/casualty lines. Hannover Re ranks as the third-largest reinsurance group in the world and is listed on the Frankfurt Stock Exchange under the ticker symbol HNR1.
- Ticker
- €HNR1
- Sector
- Finance
- Primary listing
- XETRA
- Employees
- 4,090
- Headquarters
- Hanover, Germany
- Website
- www.hannover-re.com
Hannover Re Metrics
BasicAdvanced
€34B
12.51
€22.66
0.12
€12.50
4.41%
Price and volume
Market cap
€34B
Beta
0.12
52-week high
€282.80
52-week low
€223.20
Average daily volume
132K
Dividend rate
€12.50
Financial strength
Current ratio
0.196
Quick ratio
0.145
Long term debt to equity
0.289
Total debt to equity
0.29
Dividend payout ratio (TTM)
46.32%
Interest coverage (TTM)
27.09%
Profitability
EBITDA (TTM)
3,442.3
Gross margin (TTM)
18.20%
Net profit margin (TTM)
12.05%
Operating margin (TTM)
14.89%
Effective tax rate (TTM)
18.99%
Revenue per employee (TTM)
€5,540,000
Management effectiveness
Return on assets (TTM)
2.92%
Return on equity (TTM)
22.16%
Valuation
Price to earnings (TTM)
12.511
Price to revenue (TTM)
1.508
Price to book
2.58
Price to tangible book (TTM)
2.6
Price to free cash flow (TTM)
5.295
Free cash flow yield (TTM)
18.89%
Free cash flow per share (TTM)
53.539
Dividend yield (TTM)
4.41%
Forward dividend yield
4.41%
Growth
Revenue change (TTM)
-13.08%
Earnings per share change (TTM)
10.14%
3-year revenue growth (CAGR)
-4.28%
10-year revenue growth (CAGR)
3.28%
3-year earnings per share growth (CAGR)
43.49%
10-year earnings per share growth (CAGR)
9.46%
3-year dividend per share growth (CAGR)
35.72%
10-year dividend per share growth (CAGR)
14.42%
What the Analysts think about Hannover Re
Analyst ratings (Buy, Hold, Sell) for Hannover Re stock.
Analyst projections of the future price of Hannover Re stock.
Bulls say / Bears say
First-half net income rose 7% to €1.4 billion, while the combined ratio improved to 83.2%; Hannover Re kept its 2026 net-income target of at least €2.7 billion. This gives the company a strong earnings base for the year. (Hannover Re)
The 254% Solvency II ratio provides a substantial capital buffer, and the 3.7% first-half investment return was ahead of the roughly 3.5% full-year target. Life and health’s service result also grew 7.5% and was on track for its annual target, supporting earnings beyond property and casualty. (Hannover Re)
Hannover Re grew renewal volumes by 12.3% in June and July despite lower risk-adjusted prices, showing it can still find business that meets its underwriting standards. Management sees further opportunities for selective growth and expects property-cat price reductions to ease from recent levels. (Hannover Re, Hannover Re)
The reinsurance market is becoming more competitive, with Hannover Re expecting slightly lower prices at the January 2027 renewals. Continued excess capacity and soft pricing could squeeze underwriting margins if claims remain subdued and buyers gain bargaining power. (Business Insurance, Hannover Re)
New business contract service margin fell 13.3% in the first half, which the company linked mainly to lower renewal prices and currency effects. That decline points to pressure on the value of new business even as renewal volumes rise. (Hannover Re)
The €2.7 billion earnings target assumes large-loss costs do not significantly exceed the €2.3 billion budget and that capital markets avoid unforeseen disruption. A severe catastrophe year or adverse market moves could therefore make the target harder to reach. (Hannover Re)
Data summarised monthly by Lightyear AI. Last updated on 15 Oct 2026.
Hannover Re Financial Performance
Revenues and expenses
Hannover Re Earnings Performance
Company profitability
Upcoming events
No upcoming events
Funds containing Hannover Re
AllEURUSDGBP
Fund name | Fund size | €HNR1 weighting |
|---|---|---|
SPDR S&P Euro Dividend Aristocrats€EUDV | €1.8B | 3.84% |
SPDR S&P Euro Dividend Aristocrats£EUDV | €1.8B | 3.84% |
iShares DivDAX€EXSB | €562M | 3.00% |
Invesco EURO STOXX High Dividend Low Volatility£EUHD | €589M | 2.20% |
iShares STOXX Europe 600 Insurance€A0H08K | €605M | 2.10% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.